Literature DB >> 23257771

Successful management of a possible antibiotic-related acquired factor V inhibitor: a case report and review of the literature.

Pooja Motwani1, Leslie Howard, Syed S Ali.   

Abstract

Acquired factor inhibitors are rare. We report a case of an elderly male who presented with a bleeding diathesis associated with an elevated prothrombin time and an activated partial thromboplastin time. Work-up revealed undetectable factor V activity and a factor V inhibitor level of >50 Bethesda units. The inhibitor may have been triggered by antibiotics. With a multimodality approach using steroids, platelet transfusions, intravenous immunoglobulin, factor VIII inhibitor bypass activity agent and cyclophosphamide, we successfully eliminated the inhibitor and controlled the bleeding.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23257771     DOI: 10.1159/000345244

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  3 in total

1.  Transient cefuroxime/metronidazole treatment induced factor V antibodies.

Authors:  Sjoerd Adrianus Antonius Van den Berg; Patricia E Verwer; René N Idema; Coen Van Guldener
Journal:  BMJ Case Rep       Date:  2014-08-19

2.  Acquired Factor V Inhibitor.

Authors:  Daisuke Hirai; Yugo Yamashita; Nobutoyo Masunaga; Toshiaki Katsura; Masaharu Akao; Yoshiaki Okuno; Hiroshi Koyama
Journal:  Intern Med       Date:  2016-10-15       Impact factor: 1.271

3.  Successful Outcome of Severe Intra-cerebral Bleeding Associated with Acquired Factor V Inhibition: Utilization of Multiple Therapeutic Agents.

Authors:  Panagiotis Andreadis; Katerina Kafantari; Aleka Agapidou; Sofia Vakalopoulou; Efthymia Vlachaki
Journal:  Balkan Med J       Date:  2017-09-13       Impact factor: 2.021

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.